Francois Lionnet
Overview
Explore the profile of Francois Lionnet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabate-Elabbadi A, Mekontso-Dessap A, Lionnet F, Santin A, Verdet C, Woerther P, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101234.
PMID: 39995490
Background: Respiratory infection may account for 30% of acute chest syndrome (ACS) aetiologies. However, antimicrobials are routinely prescribed, and de-escalation and/or discontinuation are challenging. Multiplex Polymerase Chain Reaction (mPCR) with...
2.
Beurier P, Dallevet C, Brissot E, Cholet C, Santin A, Lionnet F, et al.
Rev Med Interne
. 2024 Aug;
45(8):512-515.
PMID: 39112315
Introduction: Periarteritis nodosa (PAN) is a vasculitis affecting medium-vessel and may be associated with myelodysplastic syndrome. This association needs a simultaneous treatment of the vascular and the hematological disease. However...
3.
Stojanovic K, Santin A, Veyssier-Belot C, Arlet J, Lionnet F
Eur J Intern Med
. 2024 May;
127:151-153.
PMID: 38744594
No abstract available.
4.
Borgey M, Genty I, Habibi A, Arlet J, Dhedin N, Lionnet F, et al.
Am J Hematol
. 2024 Apr;
99(8):1601-1605.
PMID: 38686944
No abstract available.
5.
de Berny Q, Saint-Jacques C, Santin A, Mattioni S, Steichen O, Chieze R, et al.
Am J Physiol Renal Physiol
. 2023 Dec;
326(2):F278-F284.
PMID: 38059298
The urine concentration impairment responsible for hyposthenuria in sickle cell nephropathy is currently thought to be a consequence of renal medulla lesions, which lead to nephrogenic diabetes insipidus. The objective...
6.
Joseph L, De Luna G, Bernit E, Cougoul P, Santin A, Faucher B, et al.
Haematologica
. 2023 Oct;
109(5):1562-1565.
PMID: 37855041
No abstract available.
7.
Pondarre C, Lionnet F
Rev Prat
. 2023 Jun;
73(5):522-526.
PMID: 37309788
DISEASE MODIFYING TREATMENTS FOR SICKLE CELL DISEASE. The two most widely available disease-modifying therapies, hydroxycarbamide and long-term redblood cells transfusions, are mostly introduced after the occurrence of complications. Hydroxycarbamide is...
8.
9.
Kolanska K, Vasileva R, Lionnet F, Santin A, Jaudi S, Dabi Y, et al.
J Gynecol Obstet Hum Reprod
. 2022 Jan;
51(3):102328.
PMID: 35093595
Introduction: The effect of coronavirus disease (COVID-19) on pregnancy outcome in women with sickle cell disease (SCD) is unknown. Objectives: To analyze the severity of the SARS-CoV-2 infection in pregnant...
10.
Arlet J, Lionnet F, Khimoud D, Joseph L, De Montalembert M, Morisset S, et al.
Am J Hematol
. 2021 Dec;
97(3):E86-E91.
PMID: 34882837
No abstract available.